CTOs on the Move

Cyrano Therapeutics

www.cyranotherapeutics.com

 
The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Cyrano Therapeutics raised $12.8M on 12/10/2020

Similar Companies

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.

Accuro Diagnostic Imaging

Accuro Diagnostic Imaging is a Ellenton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GeneCopoeia

GeneCopoeia is a Germantown, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metro Optics Inc

Metro Optics Inc is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

California Home Medical Eqpt

California Home Medical Eqpt is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.